Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

doi:10.1038/s41591-020-0901-9

. 2020 Jun;26(6):842-844.

doi: 10.1038/s41591-020-0901-9. Epub 2020 May 12.

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Mingfeng Liao^#¹, Yang Liu^#¹, Jing Yuan^#², Yanling Wen¹, Gang Xu¹, Juanjuan Zhao¹, Lin Cheng¹, Jinxiu Li², Xin Wang¹, Fuxiang Wang², Lei Liu^{3

4}, Ido Amit⁵, Shuye Zhang⁶, Zheng Zhang^{7

8}

Affiliations

¹ Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
² Department for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
³ Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China. liulei3322@aliyun.com.
⁴ The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China. liulei3322@aliyun.com.
⁵ Department of Immunology, Weizmann Institute of Science, Rehovot, Israel. ido.amit@weizmann.ac.il.
⁶ Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. zhangshuye@shphc.org.cn.
⁷ Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China. zhangzheng1975@aliyun.com.
⁸ The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China. zhangzheng1975@aliyun.com.

^# Contributed equally.

PMID: 32398875
DOI: 10.1038/s41591-020-0901-9

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Mingfeng Liao et al. Nat Med. 2020 Jun.

. 2020 Jun;26(6):842-844.

doi: 10.1038/s41591-020-0901-9. Epub 2020 May 12.

Authors

Affiliations

¹ Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
² Department for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
³ Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China. liulei3322@aliyun.com.
⁴ The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China. liulei3322@aliyun.com.
⁵ Department of Immunology, Weizmann Institute of Science, Rehovot, Israel. ido.amit@weizmann.ac.il.
⁶ Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. zhangshuye@shphc.org.cn.
⁷ Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China. zhangzheng1975@aliyun.com.
⁸ The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China. zhangzheng1975@aliyun.com.

^# Contributed equally.

PMID: 32398875
DOI: 10.1038/s41591-020-0901-9

Abstract

Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19) severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells from patients with varying severity of COVID-19 and from healthy people by using single-cell RNA sequencing. Proinflammatory monocyte-derived macrophages were abundant in the bronchoalveolar lavage fluid from patients with severe COVID-9. Moderate cases were characterized by the presence of highly clonally expanded CD8⁺ T cells. This atlas of the bronchoalveolar immune microenvironment suggests potential mechanisms underlying pathogenesis and recovery in COVID-19.

PubMed Disclaimer

Comment in

Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.
He J, Cai S, Feng H, Cai B, Lin L, Mai Y, Fan Y, Zhu A, Huang H, Shi J, Li D, Wei Y, Li Y, Zhao Y, Pan Y, Liu H, Mo X, He X, Cao S, Hu F, Zhao J, Wang J, Zhong N, Chen X, Deng X, Chen J. He J, et al. Protein Cell. 2020 Sep;11(9):680-687. doi: 10.1007/s13238-020-00752-4. Protein Cell. 2020. PMID: 32671793 Free PMC article. No abstract available.

Cited by

T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination.
Notarbartolo S. Notarbartolo S. Vaccines (Basel). 2024 Sep 30;12(10):1126. doi: 10.3390/vaccines12101126. Vaccines (Basel). 2024. PMID: 39460293 Free PMC article. Review.
COVID-19: Immunology, Immunopathogenesis and Potential Therapies.
Bhardwaj A, Sapra L, Saini C, Azam Z, Mishra PK, Verma B, Mishra GC, Srivastava RK. Bhardwaj A, et al. Int Rev Immunol. 2022;41(2):171-206. doi: 10.1080/08830185.2021.1883600. Epub 2021 Feb 27. Int Rev Immunol. 2022. PMID: 33641587 Free PMC article. Review.
Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection.
Degauque N, Haziot A, Brouard S, Mooney N. Degauque N, et al. FASEB J. 2021 May;35(5):e21577. doi: 10.1096/fj.202100024R. FASEB J. 2021. PMID: 33831263 Free PMC article. Review.
Correlation between Type I Interferon Associated Factors and COVID-19 Severity.
Bencze D, Fekete T, Pázmándi K. Bencze D, et al. Int J Mol Sci. 2022 Sep 19;23(18):10968. doi: 10.3390/ijms231810968. Int J Mol Sci. 2022. PMID: 36142877 Free PMC article. Review.
Accurate estimation of pathway activity in single cells for clustering and differential analysis.
Davis D, Wizel A, Drier Y. Davis D, et al. Genome Res. 2024 Jul 23;34(6):925-936. doi: 10.1101/gr.278431.123. Genome Res. 2024. PMID: 38981682 Free PMC article.

See all "Cited by" articles

References

1. Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-Infected mice. Cell Host Microbe 19, 181–193 (2016). - DOI
1. Liu, L. et al. Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019). - DOI
1. Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269–270 (2020). - DOI
1. Morse, C. et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J. 54, 1802441 (2019). - DOI
1. Reyfman, P. A. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 1517–1536 (2019). - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

202002073000002/Shenzhen Science and Technology Innovation Commission/International

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- H1 Connect - Access expert opinions and insights on biomedical research.
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
Molecular Biology Databases
- NIAID Data Ecosystem - Find datasets on Infectious and Immune-mediated Diseases
Research Materials
- NCI CPTC Antibody Characterization Program

[1] Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-Infected mice. Cell Host Microbe 19, 181–193 (2016). - DOI

[2] Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-Infected mice. Cell Host Microbe 19, 181–193 (2016). - DOI

[3] Liu, L. et al. Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019). - DOI

[4] Liu, L. et al. Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019). - DOI

[5] Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269–270 (2020). - DOI

[6] Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269–270 (2020). - DOI

[7] Morse, C. et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J. 54, 1802441 (2019). - DOI

[8] Morse, C. et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J. 54, 1802441 (2019). - DOI

[9] Reyfman, P. A. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 1517–1536 (2019). - DOI

[10] Reyfman, P. A. et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 1517–1536 (2019). - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Affiliations

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Authors

Affiliations

Abstract

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Research Materials

Abstract

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Research Materials